Medgenics, Inc., the developer of BiopumpTM a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced a patent granted by the U.S. Patent and Trademark Office (USPTO) protecting the use of Medgenics' EPODURE Biopump technology for delivery of erythropoietin (EPO).
URL: http://www.news-medical.net/news/20121122/Medgenicse28099-EPODURE-Biopump-technology-for-EPO-delivery-receives-US-patent.aspx
No comments:
Post a Comment